Since launching as a spin-out from the University of Oxford, we have developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.
Our expert team of clinicians, stroke neurologists, scientists, business professionals and engineers have the necessary insight and experience to confidently serve the world’s most demanding clinical communities.
Brainomix is a private company backed by leading healthtech investors, including Boehringer Ingelheim Venture Fund, Parkwalk, and Tencent Holdings.